Physicians who care for the most socially disadvantaged patients were more likely to receive lower scores in a Centers for Medicare & Medicaid Services (CMS) program that financially rewards high-value care than physicians who care for more affluent populations, according to a study by Weill Cornell Medicine researchers.
Drawing on New York’s diverse population, Weill Cornell Medicine scientists have been awarded grants from the New York Genome Center (NYGC) to study how several types of cancer differ in patients with different genetic backgrounds and point to precision treatments for groups that have been historically underrepresented in cancer research.
An intercampus research team at Weill Cornell Medicine and Cornell’s Ithaca campus has been awarded a five-year, $3.65 million grant from the National Institutes of Health (NIH) to develop a quick, inexpensive method for accurately diagnosing urinary tract infections in kidney transplant patients by carrying out molecular profiling of cell-free DNA in urine.
Dr. Manish A. Parikh, an internationally renowned clinical interventional cardiologist and educator, has been named chief of cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital.
Cancer cells rearrange, copy, and delete their DNA in complex but distinct patterns, according to new research from a multi-institution team led by investigators at Weill Cornell Medicine and the New York Genome Center. The investigators developed sophisticated new algorithms to analyze nearly 3,000 genome sequences from human tumors.
Weill Cornell Medicine’s debt-free initiative, now a year old, expanded the institution’s scholarship offerings to provide debt-free education to all medical students with demonstrated financial need. The program replaced student loans with scholarships that cover tuition, housing and other living expenses.
As the newly appointed senior managing director with the Center for Technology Licensing (CTL) at Cornell University, Dr. Lisa Placanica will lead technology licensing efforts at Weill Cornell Medicine.
A team led by Weill Cornell Medicine scientists has pioneered a method for manufacturing functioning human blood vessels and demonstrated that they can carry blood in lab-grown model organs and tumors.
With highly qualified doctors needed now more than ever, Weill Cornell Medicine-Qatar welcomed its new cohort of incoming students with a comprehensive three-day orientation program – delivered fully online this year for the first time in the institution’s history.
A preclinical model of a common type of breast cancer provides new insight into why an immunotherapy known as checkpoint inhibition has not yet been effective against the cancer
The risks of stroke and heart failure in an individual increase as the number of social determinants of health increase, according to two new studies by Weill Cornell Medicine investigators. The social factors that affect health include race, education level, annual household income and neighborhood poverty.
Dr. John Leonard, an esteemed physician-scientist who specializes in lymphoma research and treatment, has been named senior associate dean for innovation and initiatives at Weill Cornell Medicine.
On Aug. 18, the Weill Cornell Medical College Class of 2024 gathered virtually for an online matriculation ceremony that welcomed them to the start of their medical training at the institution.
Dr. Bishoy Faltas works to develop more effective therapies for bladder cancer, a disease that’s notoriously hard to treat—and historically under-studied
The greatly increased risk of cancer and cancer mortality with aging may be due in part to the buildup in the body of a key cancer-promoting molecule, according to new preclinical research from scientists at Weill Cornell Medicine.
Abnormal immune activity in lupus, a chronic disease that can cause rashes, fatigue, joint pain, and kidney failure, seems to occur mostly in small subsets of immune cells in patients, potentially enabling better targeting for future treatments, according to a study from scientists at Weill Cornell Medicine and The Jackson Laboratory for Genomic Medicine.
Tiny packets called extracellular vesicles and particles (EVPs), released by cancer and immune cells, contain specific proteins that may serve as reliable biomarkers for diagnosing early-stage cancer, according to investigators at Weill Cornell Medicine and Memorial Sloan Kettering.
